Cytiva AxiChrom 450 Chromatography Column Pilot to Production System
Cytiva
Details
-
CategoryProcess / Scale-Up
-
Dimension30.0in x 52.0in x 67.0in
-
Serial29696971
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The Cytiva AxiChrom 450/500 Chromatography Column is a configurable platform designed to simplify column handling from pilot to large-scale production. It features intelligent axial compression and automated packing technology, providing precise control over chromatographic performance. The platform accommodates a range of resin types including BioProcess resins and high-flow options like Capto and MabSelect, ensuring compatibility and efficiency in biopharmaceutical process development. Ideal for multipurpose facilities, the AxiChrom column boasts excellent handling and maintenance features, with sizes ranging from 50 to 2000 mm. Constructed from materials compliant with biopharmaceutical standards, this platform reduces downtime and operator error while maintaining high productivity and reliability. The column, in like-new condition, enhances operational excellence and supports integration with advanced DeltaV control systems.
Key Features
- Axial compression technology
- Automated packing methods
- Broad resin compatibility
- Easy handling and maintenance
- Robust construction for biopharma use
Specifications
- Axial compression for precise control
- Suitable for resins: BioProcess, Capto, MabSelect
- Size range: 50 mm to 2000 mm inner diameter
- Compatible with ÄKTA and BioProcess systems
- Materials meet USP Class VI, ASME Bioprocessing Equipment standards
Weight
Imperial: 1200.0 Pounds
Metric: 544.31 Kilograms
Shipping Dimensions
Imperial: 36.0 lb x 62.4 lb x 80.4 lb
Metric: 91.44 cm x 158.5 cm x 204.22 cm
Harmonized Code
9027.80.45
Harmonized Code Details
9027.80.45 - Chromatography apparatus. This code is used for equipment designed for molecular chromatography, which is applicable for biopharmaceutical manufacturing processes.
Comments 0
There are currently no public comments.